Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy

Locoregional treatments of metastatic internal mammary node following neoadjuvant chemotherapy

Saved in:

Bibliographic Details
Main Authors:	Jinhui Zhang, Huajie Guan, Cailu Song, Lingrui Liu, Hailin Tang, Jin Wang, Ting Gao
Format:	Article
Language:	English
Published:	Wolters Kluwer 2025-02-01
Series:	Chinese Medical Journal
Online Access:	http://journals.lww.com/10.1097/CM9.0000000000003397
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels
by: Jun Takahashi, et al.
Published: (2018-01-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2007-03-01)

Breast Cancer: Neoadjuvant Chemotherapy
by: Barbara F. Shea, et al.
Published: (2015-05-01)

FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer
by: Shun Zhang, et al.
Published: (2020-01-01)

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy
by: M.C. Van Maaren, et al.
Published: (2025-02-01)

Chemotherapy for Metastatic Gastric Cancer
by: Sung Eun Kim, et al.
Published: (2025-01-01)

Nodular Regenerative Hyperplasia Secondary to Neoadjuvant Chemotherapy for Colorectal Liver Metastases
by: Maartje A. J. van den Broek, et al.
Published: (2009-01-01)

Anti-programmed death-1 inhibitors and nimotuzumab in combination with induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis
by: Ya-Ni Zhang, et al.
Published: (2025-01-01)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
by: Hamid Reza Mirzaei, et al.
Published: (2013-01-01)

Indocyanine Green Fluorescence Plus Blue Dye for Sentinel Lymph Node Biopsy in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter, Prospective Cohort Study
by: Miao Liu, et al.
Published: (2025-01-01)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
by: Hiroyuki Iwasaki, et al.
Published: (2020-01-01)

Small Cell Neuroendocrine Carcinoma of the Urinary Tract Successfully Managed with Neoadjuvant Chemotherapy
by: Mustapha Ahsaini, et al.
Published: (2013-01-01)

Does Apoptotic Index Predict the Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma?
by: Gokce ASKAN, et al.
Published: (2023-03-01)

Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
by: Yonghe Chen, et al.
Published: (2021-01-01)

Can Gastric Cancer Patients with High Mandard Score Benefit from Neoadjuvant Chemotherapy?
by: Wen-Zhe Kang, et al.
Published: (2022-01-01)

Clinical Effectiveness of Neoadjuvant Chemotherapy in Gastric Carcinoma and Exploration of Perioperative Imaging Assessment Parameters
by: Jiajun Lai, et al.
Published: (2021-01-01)

Impact of Neoadjuvant Chemotherapy and Preoperative Irradiation on Early Complications in Direct-to-Implant Breast Reconstruction
by: Ji Won Hwang, et al.
Published: (2024-09-01)

Chemoradiotherapy in a Case of Malignant Syringocystadenocarcinoma Papilliferum of Vulva with Locoregional Failure
by: Pamidimukkala Bramhananda Rao, et al.
Published: (2015-01-01)

The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer
by: Ting Xu, et al.
Published: (2024-01-01)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
by: Jian Zhang, et al.
Published: (2022-03-01)

Multimodal treatment with Neoadjuvant chemotherapy for eyelid and periocular sebaceous gland carcinoma: Long-term outcomes
by: Vijitha S. Vempuluru, et al.
Published: (2025-06-01)

Assessment of Pathological Response of Breast Carcinoma in Modified Radical Mastectomy Specimens after Neoadjuvant Chemotherapy
by: Dhanya Vasudevan, et al.
Published: (2015-01-01)

Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
by: Yuan Tian, et al.
Published: (2021-01-01)

Incidental Finding and Endovascular Repair of a Left Internal Mammary Artery Aneurysm following a Multivessel Coronary Artery Bypass Graft
by: Osayi Lawani, et al.
Published: (2021-01-01)

Neoadjuvant programmed death ligand-1 with chemotherapy versus chemotherapy alone for limited-stage small-cell lung cancer: a retrospective study
by: Zhi Yang, et al.
Published: (2025-01-01)

Pathologic Complete Response to Neoadjuvant Nivolumab/Ipilimumab in a Patient with Metastatic Renal Cell Carcinoma
by: Taylor C. Peak, et al.
Published: (2020-01-01)

The Value of Combined Large Format Histopathology Technique to Assess the Surgically Removed Breast Tissue following Neoadjuvant Chemotherapy: A Single Institution Study of 40 Cases
by: Julio A. Ibarra
Published: (2012-01-01)

Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
by: Brian Hu, et al.
Published: (2018-01-01)

Carcinoembryonic antigen trajectory predicts pathological complete response in advanced gastric cancer after neoadjuvant chemotherapy
by: Yonghe Chen, et al.
Published: (2025-02-01)

Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis
by: Bin Zhong, et al.
Published: (2025-01-01)

Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01)

Comparative survival outcomes of neoadjuvant and adjuvant therapy in patients with T1c, node-negative, triple-negative breast cancer: A population-based analysis
by: Yi-Zi Zheng, et al.
Published: (2025-02-01)

The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study
by: Mahvish Muzaffar, et al.
Published: (2018-01-01)

Metastatic Malignant Melanoma of the Inguinal Lymph Node with Unknown Primary Lesion
by: Sherif Ali Eltawansy, et al.
Published: (2015-01-01)

Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node
by: Jien Shim, et al.
Published: (2018-01-01)

Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer
by: V. V. Astashov, et al.
Published: (2023-06-01)

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
by: Ning Zhang, et al.
Published: (2025-01-01)

Inflammatory burden index as a prognostic marker in patients with advanced gastric cancer treated with neoadjuvant chemotherapy and immunotherapy
by: Jiao-Bao Huang, et al.
Published: (2025-01-01)